Navigation Links
Bonn researchers use light to make the heart stumble
Date:10/4/2010

This release is available in German.

Tobias Brgmann and his colleagues from the University of Bonn's Institute of Physiology I used a so-called "channelrhodopsin" for their experiments, which is a type of light sensor. At the same time, it can act as an ion channel in the cell membrane. When stimulated with blue light, this channel opens, and positive ions flow into the cell. This causes a change in the cell membrane's pressure, which stimulates cardiac muscle cells to contract.

"We have genetically modified mice to make them express channelrhodopsin in the heart muscle," explains Professor Dr. Bernd Fleischmann of the Institute for Physiology I. "That allowed us to change the electric potential of the mouse heart at will, enabling us to selectively produce conditions such as arrhythmia of the atrium or the ventricle."

These types of arrhythmia - physicians also call them ventricular fibrillation - are among the most common causes of death after a heart attack. They develop when large quantities of cardiac cells die and are replaced with connective tissue. "This scar tissue has a different electrical activity than the healthy heart muscle," says the leader of the study, Professor Dr. Philipp Sasse. "And that makes the heart stumble."

But why is that so? Normally, electric impulses spread across the heart from a natural pacemaker. This happens in a temporally and spatially tightly controlled manner, creating a closely coordinated contraction. However, if entire muscle areas decouple electrically, this mechanism no longer works: all of a sudden, certain parts of the heart pulse at their own rhythm. This causes the blood flow to come to a near-standstill.

The scientists from Bonn can now trigger this decoupling through photostimulation. They can target just a few cells at a time or direct larger areas of the heart, allowing them to find out, for instance, which areas of the hollow muscle are especially sensitive to electric disruptions.

But why not simply stimulate the heart muscle with electrodes in order to make the heart lose its rhythm? "That can be done as well," says Professor Sasse. " But this method has unwanted side effects: if the electric stimulation lasts longer than a few milliseconds, toxic gases are produced, and the pH value changes."

The consequences of a heart attack, which leads to permanent tissue damage, can of course only be studied in a very limited form when using short-term electric stimulation. Photostimulation is much more suitable: the cells will even withstand stimulations of several minutes at a time without problems.

Using channelrhodopsin in medical research is not fundamentally new, although so far it has mainly been used in neuroscience. For instance, scientists can use these light channels to direct the behavior of flies and mice - with nothing but blue light.


'/>"/>

Contact: Professor Dr. Philipp Sasse
philipp.sasse@uni-bonn.de
49-228-688-5212
University of Bonn
Source:Eurekalert

Related biology news :

1. Researchers engineer adult stem cells that do not age
2. OU researchers selected by Navy
3. Researchers find first genetic evidence for loss of teeth in the common ancestor of baleen whales
4. McLean Hospital researchers awarded $1.9 9 million grant for stem cell, blood research
5. WSU researchers taking sustainability of organic farming to new level
6. Purifying proteins: Rensselaer researchers use NMR to improve drug development
7. Smithsonian researchers find differences between Galapagos and mainland frigatebirds
8. Iowa State, Ames Lab researchers identify structure that allows bacteria to resist drugs
9. Vitamin C rapidly improves emotional state of acutely hospitalized patients, say LDI researchers
10. BUSM researchers to study vitamin D production in fat malabsorption patients
11. Cardiovascular Innovation Institute researchers receive over $2 million grant from NIH
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/12/2016)... , May 12, 2016 WearablesResearch.com ... just published the overview results from the Q1 wave ... the recent wave was consumers, receptivity to a program ... data with a health insurance company. "We ... to share," says Michael LaColla , CEO of ...
(Date:4/26/2016)... and LONDON , April ... part of EdgeVerve Systems, a product subsidiary of ... today announced a partnership to integrate the Onegini ...      (Logo: http://photos.prnewswire.com/prnh/20151104/283829LOGO ) ... their customers enhanced security to access and transact ...
(Date:4/14/2016)... April 14, 2016 BioCatch ... Detection, today announced the appointment of Eyal Goldwerger ... role. Goldwerger,s leadership appointment comes at a ... of the deployment of its platform at several of ... technology, which discerns unique cognitive and physiological factors, is ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... , June 23, 2016   Boston ... of novel compounds designed to target cancer stemness ... has been granted Orphan Drug Designation from the ... treatment of gastric cancer, including gastroesophageal junction (GEJ) ... inhibitor designed to inhibit cancer stemness pathways by ...
(Date:6/23/2016)... MONICA, Calif. , June 23, 2016  The Prostate Cancer Foundation ... pioneer increasingly precise treatments and faster cures for prostate cancer. Members of the ... institutions across 15 countries. Read More About the Class ... ... ...
(Date:6/23/2016)... , ... June 23, 2016 , ... In a new ... in Denmark detail how a patient who developed lymphedema after being treated for breast ... results could change the paradigm for dealing with this debilitating, frequent side effect of ...
(Date:6/23/2016)... Francisco, CA (PRWEB) , ... June 23, 2016 ... ... (EDC) software, is exhibiting at the Pennsylvania Convention Center and will showcase its ... Annual conference. ClinCapture will also be presenting a scientific poster on Disrupting Clinical ...
Breaking Biology Technology: